Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Neurocritical Care
Published in: Neurocritical Care 3/2006

01-12-2006 | Translational Research

A novel inhibitor of inflammatory cytokine production (CNI-1493) reduces rodent post-hemorrhagic vasospasm

Authors: George Bowman, Robert H. Bonneau, Vernon M. Chinchilli, Kevin J. Tracey, Kevin M. Cockroft

Published in: Neurocritical Care | Issue 3/2006

Login to get access
Metadata
Title
A novel inhibitor of inflammatory cytokine production (CNI-1493) reduces rodent post-hemorrhagic vasospasm
Authors
George Bowman
Robert H. Bonneau
Vernon M. Chinchilli
Kevin J. Tracey
Kevin M. Cockroft
Publication date
01-12-2006
Publisher
Humana Press
Published in
Neurocritical Care / Issue 3/2006
Print ISSN: 1541-6933
Electronic ISSN: 1556-0961
DOI
https://doi.org/10.1385/NCC:5:3:222

Other articles of this Issue 3/2006

Neurocritical Care 3/2006 Go to the issue

Letter to the Editor

Response by the authors

Editorial

Is it worthwhile to use cerebral microdialysis in patients with acute liver failure?

Original Article

Seizure detection in adult ICU patients based on changes in EEG synchronization likelihood

Letter to the Editor

Central nervous system vasculitis following pneumococcal meningitis

Review

Mechanisms in neurogenic stress cardiomyopathy after aneurysmal subarachnoid hemorrhage

Perspectives in GBS

Long-term outcome of Guillain-Barré syndrome